Advances in identifying subpopulations of cancer cells and reconstructing the clonal evolution of tumors greatly enhance our understanding of the molecular events within a patient and their context relative to one another. In the rapidly unfolding era of personalized medicine, the ability to monitor clonal dynamics throughout patient care has significant clinical implications for the appropriate development or application of targeted therapies as well as understanding the potential mechanisms driving resistance. In this review, we discuss advances in biotechnology and bioinformatics that improve precision treatment by dissecting clonal evolution, focusing first on the initial discoveries in lymphomas and leukemias followed by the more recent applications to advance our understanding of prostate cancer (PCa).

Original languageEnglish
Pages (from-to)1464-1469
Number of pages6
JournalDrug Discovery Today
Issue number12
StatePublished - Dec 1 2015


Dive into the research topics of 'Clonotyping for precision oncology'. Together they form a unique fingerprint.

Cite this